VEGFR-3 plays a crucial role in tumor progression and metastasis. Many tumors overexpress VEGFR-3, which contributes to enhanced lymphangiogenesis and the development of lymphatic metastases. This overexpression is often correlated with poor prognosis and increased tumor aggressiveness.
